Your browser doesn't support javascript.
loading
De novo DNA methylation by DNA methyltransferase 3a controls early effector CD8+ T-cell fate decisions following activation.
Ladle, Brian H; Li, Kun-Po; Phillips, Maggie J; Pucsek, Alexandra B; Haile, Azeb; Powell, Jonathan D; Jaffee, Elizabeth M; Hildeman, David A; Gamper, Christopher J.
Afiliação
  • Ladle BH; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD 21231; bladle@jhmi.edu David.Hildeman@cchmc.org.
  • Li KP; Immunology Graduate Program, University of Cincinnati College of Medicine, Cincinnati, OH 45220; Division of Immunobiology, Department of Pediatrics, Cincinnati Children's Hospital, University of Cincinnati College of Medicine, Cincinnati, OH 45229.
  • Phillips MJ; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD 21231;
  • Pucsek AB; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD 21231;
  • Haile A; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD 21231;
  • Powell JD; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD 21231;
  • Jaffee EM; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD 21231;
  • Hildeman DA; Immunology Graduate Program, University of Cincinnati College of Medicine, Cincinnati, OH 45220; Division of Immunobiology, Department of Pediatrics, Cincinnati Children's Hospital, University of Cincinnati College of Medicine, Cincinnati, OH 45229 bladle@jhmi.edu David.Hildeman@cchmc.org.
  • Gamper CJ; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD 21231;
Proc Natl Acad Sci U S A ; 113(38): 10631-6, 2016 09 20.
Article em En | MEDLINE | ID: mdl-27582468
ABSTRACT
DNMT3a is a de novo DNA methyltransferase expressed robustly after T-cell activation that regulates plasticity of CD4(+) T-cell cytokine expression. Here we show that DNMT3a is critical for directing early CD8(+) T-cell effector and memory fate decisions. Whereas effector function of DNMT3a knockout T cells is normal, they develop more memory precursor and fewer terminal effector cells in a T-cell intrinsic manner compared with wild-type animals. Rather than increasing plasticity of differentiated effector CD8(+) T cells, loss of DNMT3a biases differentiation of early effector cells into memory precursor cells. This is attributed in part to ineffective repression of Tcf1 expression in knockout T cells, as DNMT3a localizes to the Tcf7 promoter and catalyzes its de novo methylation in early effector WT CD8(+) T cells. These data identify DNMT3a as a crucial regulator of CD8(+) early effector cell differentiation and effector versus memory fate decisions.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: DNA (Citosina-5-)-Metiltransferases / Fator 1-alfa Nuclear de Hepatócito / Fator 1 de Transcrição de Linfócitos T / Memória Imunológica Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: DNA (Citosina-5-)-Metiltransferases / Fator 1-alfa Nuclear de Hepatócito / Fator 1 de Transcrição de Linfócitos T / Memória Imunológica Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2016 Tipo de documento: Article